Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For May 13, 2020

Share:

Upgrades

  • Oppenheimer changed the rating for Inter Parfums Inc (NASDAQ: IPAR) from Underperform to Neutral. In the first quarter, Inter Parfums showed an EPS of $0.32, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $81.40 and a 52-week-low of $34.20. Inter Parfums's stock last closed at $41.67 per share.
  • For Charles River Laboratories International Inc (NYSE: CRL), UBS upgraded the stock from Neutral to Buy. Charles River earned $1.84 in the first quarter, compared to $1.40 in the year-ago quarter. The stock has a 52-week-high of $179.38 and a 52-week-low of $95.58. Charles River's stock last closed at $161.19 per share.
  • UBS upgraded the stock for Covanta Holding Corp (NYSE: CVA) from Neutral to Buy. For the first quarter, Covanta Holding had an EPS of ($0.10), compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $18.38 and a 52-week-low of $6.57. Covanta Holding's stock last closed at $8.38 per share.
  • For Inter Parfums Inc (NASDAQ: IPAR), DA Davidson upgraded the stock from Underperform to Neutral. Inter Parfums earned $0.32 in the first quarter, compared to $0.60 in the year-ago quarter. The stock has a 52-week-high of $81.40 and a 52-week-low of $34.20. Inter Parfums's stock last closed at $41.67 per share.
  • For CymaBay Therapeutics Inc (NASDAQ: CBAY), B. Riley FBR upgraded the stock from Neutral to Buy. In the first quarter, CymaBay Therapeutics showed an EPS of ($0.19), compared to ($0.37) from the year-ago quarter. The stock has a 52-week-high of $13.32 and a 52-week-low of $1.21. CymaBay Therapeutics's stock last closed at $4.18 per share.
  • Wells Fargo upgraded the stock for United Natural Foods Inc (NYSE: UNFI) from Underweight to Equal-Weight. United Natural Foods earned $0.32 in the second quarter, compared to $0.44 in the year-ago quarter. The stock has a 52-week-high of $16.70 and a 52-week-low of $5.00. United Natural Foods's stock last closed at $15.60 per share.

 

Downgrades

  • Compass Point changed the rating for TriplePoint Venture Growth BDC Corp (NYSE: TPVG) from Buy to Neutral. In the first quarter, TriplePoint Venture Gwth showed an EPS of $0.41, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $17.17 and a 52-week-low of $2.80. TriplePoint Venture Gwth's stock last closed at $8.39 per share.
  • UBS changed the rating for ONEOK Inc (NYSE: OKE) from Buy to Neutral. For the first quarter, ONEOK had an EPS of $0.83, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $78.48 and a 52-week-low of $12.16. ONEOK's stock last closed at $33.03 per share.
  • For Quaker Chemical Corp (NYSE: KWR), Janney Capital downgraded the stock from Buy to Neutral. Quaker Chemical earned $1.38 in the first quarter, compared to $1.41 in the year-ago quarter. The stock has a 52-week-high of $209.05 and a 52-week-low of $108.14. Quaker Chemical's stock last closed at $166.06 per share.
  • Loop Capital changed the rating for Steven Madden Ltd (NASDAQ: SHOO) from Buy to Hold. Steven Madden earned $0.39 in the fourth quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $44.80 and a 52-week-low of $16.38. Steven Madden's stock last closed at $21.65 per share.
  • Morgan Stanley downgraded the stock for Xcel Energy Inc (NASDAQ: XEL) from Equal-Weight to Underweight. For the first quarter, Xcel Energy had an EPS of $0.56, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $72.14 and a 52-week-low of $46.58. Xcel Energy's stock last closed at $58.79 per share.
  • Credit Suisse changed the rating for Valaris PLC (NYSE: VAL) from Neutral to Underperform. Valaris earned ($1.66) in the first quarter. The stock has a 52-week-high of $8.75 and a 52-week-low of $0.30. Valaris's stock last closed at $0.37 per share.
  • Raymond James downgraded the stock for Spirit Airlines Inc (NYSE: SAVE) from Outperform to Market Perform. For the first quarter, Spirit Airlines had an EPS of ($0.86), compared to year-ago quarter EPS of $0.84. The stock has a 52-week-high of $55.21 and a 52-week-low of $7.01. Spirit Airlines's stock last closed at $9.44 per share.
  • Morgan Stanley downgraded the stock for Radius Health Inc (NASDAQ: RDUS) from Overweight to Equal-Weight. In the first quarter, Radius Health showed an EPS of ($0.59), compared to ($0.70) from the year-ago quarter. The stock has a 52-week-high of $29.97 and a 52-week-low of $10.32. Radius Health's stock last closed at $13.84 per share.

 

Initiations

  • With a rating of Outperform, Cowen & Co. initiated coverage on Theravance Biopharma Inc (NASDAQ: TBPH). The price target is set at $42.00 for Theravance Biopharma. Theravance Biopharma earned ($1.14) in the first quarter, compared to ($1.32) in the year-ago quarter. The stock has a 52-week-high of $31.54 and a 52-week-low of $15.18. Theravance Biopharma's stock last closed at $28.49 per share.
  • With a rating of Buy, HC Wainwright & Co. initiated coverage on Fate Therapeutics Inc (NASDAQ: FATE). The price target is set at $42.00 for Fate Therapeutics. Fate Therapeutics earned ($0.44) in the first quarter, compared to ($0.30) in the year-ago quarter. The stock has a 52-week-high of $32.39 and a 52-week-low of $12.59. Fate Therapeutics's stock last closed at $28.75 per share.
 

Related Articles (CRL + CBAY)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
AMZNJP MorganMaintains4,600.0
STZOTR GlobalDowngrades
SYKESidoti & Co.Downgrades54.0
CAIB. Riley SecuritiesDowngrades
UALWolfe ResearchUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com